Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 13, 2017
Event: Regulation FD Disclosure (Item 7.01) regarding an investor presentation furnished as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of an investor presentation and does not contain audited financial statements or specific financial data points.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The document references an attached presentation (Exhibit 99.1) which may contain such information, but the content of that presentation is not included in the provided text.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor presentation dated November 2017 for use in meetings with investors or analysts.
Legal Status: The information in this report and the attached exhibit is furnished pursuant to Item 7.01 and is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and will not be incorporated by reference into other filings unless expressly referenced.
Investor Verification Checklist
- Review Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated November 2017) for specific financial data and strategic outlook.
- Verify if the presentation contains forward-looking statements that differ from previous guidance.
- Confirm the date and content of the investor meetings referenced in the filing.